Measuring Aided Language Development

NCT ID: NCT06512168

Last Updated: 2025-05-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-01

Study Completion Date

2028-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The focus of the current study is to systematically investigate the psychometric properties of a range of aided language measures, which are based on the Graphic Symbol Utterance and Sentence Development Framework (Binger \& Kent-Walsh).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Our central hypotheses are: (1) psychometrically sound measures can be established to capture growth within and across different dimensions of language acquisition, and (2) some elicitation contexts will be better than others at capturing aided language growth. Specific Aim 1 identifies valid measures to characterize aided language progress. Aim 1A uses existing data to document the psychometric properties of a range of aided language measures for preschoolers at the early stages of aided communication acquisition who have received 4 months of aided language intervention. Aim 1B analyzes language progression for high-performing aided communicators who will receive 24 months of intervention; this allows for investigation across all phases of early aided language acquisition. Specific Aim 2 identifies elicitation contexts that demonstrate the most productive aided language use. Achievement of the aims will result in measures that demonstrate strong reliability, differentiate growth for different populations, describe different dimensions of language growth, and are clinically feasible.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Down Syndrome Cerebral Palsy Apraxia of Speech Speech Sound Disorder Speech Disorders in Children Speech and Language Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment Group

AAC Generative Language Intervention

Group Type EXPERIMENTAL

AAC Generative Language Intervention

Intervention Type BEHAVIORAL

Aided AAC Language Input/Output Intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AAC Generative Language Intervention

Aided AAC Language Input/Output Intervention

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical Identification of Down Syndrome or Cerebral Palsy + Significant Speech Impairment
* Must Speak English as a Primary Language
* Must Be Able to Express At Least 25 Words (using any communication mode)
* Must Be Able to Accurately Select Picture Symbols on iPad Communication App with at Least 50% Accuracy
* Vision and Hearing within Functional Limits or Corrected to be within Functional Limits for Study Activities

Exclusion Criteria

* Clinical Diagnosis of Autism or Social Communication Disorder
* Primary Language Spoken is A Language Other than English
Minimum Eligible Age

42 Months

Maximum Eligible Age

60 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

Sponsor Role collaborator

University of New Mexico

OTHER

Sponsor Role collaborator

University of Wisconsin, Milwaukee

OTHER

Sponsor Role collaborator

University of Central Florida

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jennifer Kent-Walsh

Pegasus Professor & Associate Dean of Research

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Central Florida - Innovative Center

Orlando, Florida, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jennifer Kent-Walsh, PhD

Role: CONTACT

407-823-4800

Cathy Binger, PhD

Role: CONTACT

505-277-4453

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nancy Harrington, MA

Role: primary

(407) 882-0465

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01DC021160-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

AWD00006137

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Emergence of Generative Language
NCT02555241 COMPLETED NA
Building Complex Language
NCT01337232 COMPLETED PHASE1/PHASE2
Neural Prediction to Enhance Language
NCT05962359 RECRUITING NA